AMLX NASDAQ
Amylyx Pharmaceuticals, Inc.
1W: -11.8%
1M: -27.5%
3M: -9.7%
YTD: +11.6%
1Y: +163.2%
3Y: -54.0%
$12.74
-0.12 (-0.93%)
Weekly Expected Move ±5.5%
$12
$13
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.1B
52W Range4.64-18.605
Volume1,112,220
Avg Volume1,100,559
Beta-0.10
Dividend—
Analyst Ratings
Company Info
CEOJoshua Cohen
Employees123
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-07
Websiteamylyx.com
43 Thorndike Street
Cambridge, MA 02141
US
Cambridge, MA 02141
US
617 682 0917
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Latest News
Amylyx (AMLX) Q1 2026 Earnings Transcript
12 Health Care Stocks Moving In Friday's Pre-Market Session
Amylyx Pharmaceuticals GAAP EPS of -$0.37 misses by $0.01
[10-Q] Amylyx Pharmaceuticals, Inc. Quarterly Earnings Report - Stock Titan
Stock Traders Purchase Large Volume of Amylyx Pharmaceuticals Call Options (NASDAQ:AMLX)
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cohen Joshua B | A-Award | 248,865 | — | 2026-03-05 |
| Cohen Joshua B | A-Award | 373,295 | $14.10 | 2026-03-05 |
| Mazzariello Gina | A-Award | 74,660 | — | 2026-03-05 |
| Mazzariello Gina | A-Award | 111,990 | $14.10 | 2026-03-05 |
| FRATES JAMES M | A-Award | 95,990 | — | 2026-03-05 |